DexCom, Inc. (NASDAQ:DXCM) headquartered in San Diego, will host a conference call for the investment community to discuss the 3Q20 financial results on 27th October 2020 at 4:30 PM Eastern Time.
The conference call will also be webcast live under the investor relations section of the website www.dexcom.com
Earnings Expectation
DexCom, Inc. a medical device firm, is expected to report third quarter earnings results, after market close, on Tuesday 27th October 2020. Analysts polled by Thomson Reuters anticipate third quarter income of $ 0.64 per share from revenue of $ 476.75 million. Looking ahead, the full year income are expected at $ 2.74 per share on the revenues of $ 1869.87 million.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 1,850.00 million ~ $ 1,850.00 million
Click Here For More Historical Outlooks Of DexCom, Inc.
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company offers its systems for ambulatory use by people with diabetes; and for use by healthcare providers. Its products include DexCom G6, a CGM system for diabetes management; DexCom G5 mobile CGM system to communicate directly to patients mobile device; DexCom G4 PLATINUM system for continuous use by adults with diabetes; and DexCom Share, a remote monitoring system.
